Vaccine News and Research

Latest Vaccine News and Research

$5 million gift aims to propel Lyme disease research and education

To the Fairbairns, the symptoms--debilitating fatigue, joint pain, cognitive problems--were as worrisome as they were mystifying. All four members of the family had them.

6 Jul 2020

Human trials of potential COVID-19 vaccine commence in South Australia

A potential COVID-19 vaccine developed at Flinders University has commenced human trials in South Australia.

6 Jul 2020

Coronavirus crisis disrupts treatment for another epidemic: Addiction

Shawn Hayes was thankful to be holed up at a city-run hotel for people with COVID-19.

6 Jul 2020

Oxford COVID-19 vaccine trials move to stage 3 human trials

The technical name of the vaccine is ChAdOx1 nCoV-19 (AZD1222), as it is made from a virus called ChAdOx1, which is a weakened and non-replicating version of a common cold virus (adenovirus). The vaccine has been engineered to express the SARS-CoV-2 spike protein.

5 Jul 2020

Research suggests protective effect of influenza vaccine against COVID-19 severity and mortality

A new study involving over 92,000 patients with COVID-19 in Brazil shows that the odds of severe disease, ventilatory support requirement, and death are reduced with a recent trivalent flu vaccine. This seems to indicate that these vaccines should be used as widely as possible to reduce the risk of severe COVID-19, especially among high-risk groups. The study is published on the preprint server medRxiv* in June 2020.

5 Jul 2020

Researchers isolate protective antibodies for rare, polio-like disease in children

Researchers at Vanderbilt University Medical Center, Purdue University and the University of Wisconsin-Madison have isolated human monoclonal antibodies that potentially can prevent a rare but devastating polio-like illness in children linked to a respiratory viral infection.

3 Jul 2020

Integration of diverse set of species and environments can enhance biomedical research cycle

In an article published today in Science, a multidisciplinary research team from more than 10 universities and research institutes outlines how integrating a more diverse set of species and environments could enhance the biomedical research cycle.

3 Jul 2020

Mutated European strain of coronavirus more contagious but less potent

The coronavirus pandemic is far from over as it actively spreads across the globe. The infection toll has reached a staggering 10.84 million people since it emerged in late December 2019 in Wuhan City, China. The virus that has left the city has now spread to 188 countries and territories and has mutated, becoming more infectious.

3 Jul 2020

Effectiveness of NPI's in COVID-19 - conclusions are predictable, NPI's work

Now, a new study published on the preprint server medRxiv* looks at how the effects of these NPIs can be quantified in order to keep the public health response to COVID-19 at an adequate level. While NPIs are known to reduce the peak of the infections, in general, the researchers wanted to quantify different components separately.

2 Jul 2020

Pfizer/BioNTech COVID-19 vaccine shows promise - virus neutralizing antibodies achieved

In a recent medRxiv* paper, a research group from the U.S. and Germany showed a robust immunogenic response and a promising safety profile of the novel BNT162b1 RNA-based vaccine against coronavirus disease (COVID-19) – actively encouraging its accelerated clinical development and potential rapid production.

2 Jul 2020

Tiny balls of minerals are better vehicles for promising mRNA-based therapy

University of Wisconsin-Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination -- including a COVID-19 vaccine from Moderna Therapeutics that has advanced to clinical trials with humans.

2 Jul 2020

Controlled human infection models as a strategy to accelerate SARS-CoV-2 vaccine development

Infecting some volunteers with COVID-19 may provide valuable insights for future rounds of vaccine testing, but would require very strict controls, argues a group of infectious disease experts in the New England Journal of Medicine.

2 Jul 2020

New tools for fighting insidious Devil Facial Tumor Disease

Researchers at the University of Tasmania's Menzies Institute for Medical Research and the School of Medicine have added an arsenal of new tools (video link) to their repertoire for fighting the insidious Devil Facial Tumour Disease.

2 Jul 2020

Developing Vaccines and Therapeutics by Exploiting Structure in Spherical Nucleic Acids

An interview discussing the use of spherical nucleic acids (SNAs) and what they show about the importance of structure in pharmaceutical development.

From Pittcon 2 Jul 2020

Researchers outline checklist for implementing COVID-19 communication strategies

The COVID-19 pandemic has introduced unique challenges for public health practitioners and health communicators that warrant an expansion of existing health communication principles to take into consideration.

2 Jul 2020

ACTIV group assesses controlled human infection models for developing SARS-CoV-2 vaccine

In a Perspective for the New England Journal of Medicine, members of the National Institutes of Health's Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Vaccines Working Group assess practical considerations and prerequisites for using controlled human infection models (CHIMs), which can be used for human challenge studies, to support SARS-CoV-2 vaccine development.

2 Jul 2020

Novavax SARS-CoV-2 vaccine candidate shows promise in animal models

A new study published on the preprint server bioRxiv in June 2020 shows that a candidate spike protein vaccine can induce neutralizing antibodies, antiviral T cell responses, and protection against infection.

2 Jul 2020

Repurposed drug for acute lung injury in COVID-19

Now, a new study addresses the possible use of an FDA-approved monoclonal antibody, called fostamatinib, a spleen tyrosine kinase inhibitor (SYK), to reduce the levels of mucin-1, a molecule associated with acute lung injury and acute respiratory distress syndrome (ARDS). People who have severe COVID-19 disease may develop ARDS.

2 Jul 2020

Scientists find coronavirus' Achilles' heel

A team of scientists at the University of California San Francisco has found out how SARS-CoV-2, the virus that causes the coronavirus disease (COVID-19) invades proteins in the cells that serve as master regulators of key cellular processes.

1 Jul 2020

Which facemasks work best at stopping coronavirus?

A new study shows how wearing masks can prevent the spread of droplet borne infections and is an excellent preventive measure to stop the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study titled, "Visualizing the effectiveness of face masks in obstructing respiratory jets," is published in the latest issue of the journal Physics of Fluids.

1 Jul 2020

Vaccine News and Research

Latest Vaccine News and Research

$5 million gift aims to propel Lyme disease research and education

Human trials of potential COVID-19 vaccine commence in South Australia

Coronavirus crisis disrupts treatment for another epidemic: Addiction

Oxford COVID-19 vaccine trials move to stage 3 human trials

Research suggests protective effect of influenza vaccine against COVID-19 severity and mortality

Researchers isolate protective antibodies for rare, polio-like disease in children

Integration of diverse set of species and environments can enhance biomedical research cycle

Mutated European strain of coronavirus more contagious but less potent

Effectiveness of NPI's in COVID-19 - conclusions are predictable, NPI's work

Pfizer/BioNTech COVID-19 vaccine shows promise - virus neutralizing antibodies achieved

Tiny balls of minerals are better vehicles for promising mRNA-based therapy

Controlled human infection models as a strategy to accelerate SARS-CoV-2 vaccine development

New tools for fighting insidious Devil Facial Tumor Disease

Developing Vaccines and Therapeutics by Exploiting Structure in Spherical Nucleic Acids

Researchers outline checklist for implementing COVID-19 communication strategies

ACTIV group assesses controlled human infection models for developing SARS-CoV-2 vaccine

Novavax SARS-CoV-2 vaccine candidate shows promise in animal models

Repurposed drug for acute lung injury in COVID-19

Scientists find coronavirus' Achilles' heel

Which facemasks work best at stopping coronavirus?

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in